Extracellular microRNA: A new source of biomarkers

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 717, Issue 1-2, 2011, Pages 85-90

  Etheridge, Alton ^a   Lee, Inyoul ^a   Hood, Leroy ^a   Galas, David ^a   Wang, Kai ^a  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

Biomarker; Body fluid; Export; Extracellular; Measurement; MicroRNA

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; MICRORNA; MICRORNA 122; MICRORNA 125A; MICRORNA 126; MICRORNA 141; MICRORNA 182; MICRORNA 200A; MICRORNA 499; PARACETAMOL; UNCLASSIFIED DRUG;

ACCURACY; BIOGENESIS; BLADDER CANCER; BLOOD LEVEL; BREAST CANCER; COLORECTAL CANCER; DISEASE MARKER; DRUG OVERDOSE; HEART INFARCTION; HUMAN; LIVER TOXICITY; LUNG CANCER; MOUTH CANCER; NON INVASIVE MEASUREMENT; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

BIOLOGICAL MARKERS; HUMANS; MICRORNAS; NEOPLASMS;

EID: 82755187564     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.03.004     Document Type: Review

References (72)

1. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
2. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
3. Bartel D.P., Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 2004, 5:396-400.
4. Zhao T., Li G., Mi S., Li S., Hannon G.J., Wang X.J., Qi Y. A complex system of small RNAs in the unicellular green alga Chlamydomonas reinhardtii. Genes Dev. 2007, 21:1190-1203.
5. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23:4051-4060.
6. Borchert G.M., Lanier W., Davidson B.L. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 2006, 13:1097-1101.
7. Hu H.Y., Yan Z., Xu Y., Hu H., Menzel C., Zhou Y.H., Chen W., Khaitovich P. Sequence features associated with microRNA strand selection in humans and flies. BMC Genomics 2009, 10:413.
8. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79:351-379.
9. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002, 12:735-739.
10. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004, 5:R13.
11. Barroso-del Jesus A., Lucena-Aguilar G., Menendez P. The miR-302-367 cluster as a potential stemness regulator in ESCs. Cell Cycle 2009, 8:394-398.
12. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., Watts L., Booten S.L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B.A., Freier S., Bennett C.F., Bhanot S., Monia B.P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006, 3:87-98.
13. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577-1581.
14. Pfeffer S., Baumert T.F. Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection. Gastroenterol. Clin. Biol. 2010, 34:431-435.
15. Young D.D., Connelly C.M., Grohmann C., Deiters A. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J. Am. Chem. Soc. 2010, 132:7976-7981.
16. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., Persson R., Lindow M., Munk M.E., Kauppinen S., Orum H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
17. Niepmann M. Activation of hepatitis C virus translation by a liver-specific microRNA. Cell Cycle 2009, 8:1473-1477.
18. Lupberger J., Brino L., Baumert T.F. RNAi: a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle. J. Hepatol. 2008, 48:523-525.
19. Pan Q.W., Henry S.D., Scholte B.J., Tilanus H.W., Janssen H.L., van der Laan L.J. New therapeutic opportunities for hepatitis C based on small RNA. World J. Gastroenterol. 2007, 13:4431-4436.
20. K. Zen, C.Y. Zhang, Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers, Med. Res. Rev (2010).
21. Weber J.A., Baxter D.H., Zhang S., Huang D.Y., Huang K.H., Lee M.J., Galas D.J., Wang K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010, 56:1733-1741.
22. Wang K., Zhang S., Weber J., Baxter D., Galas D.J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010, 38:7248-7259.
23. Zubakov D., Boersma A.W., Choi Y., van Kuijk P.F., Wiemer E.A., Kayser M. MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. Int. J. Legal Med. 2010, 124:217-226.
24. Hanson E.K., Lubenow H., Ballantyne J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Anal. Biochem. 2009, 387:303-314.
25. Weickmann J.L., Glitz D.G. Human ribonucleases. Quantitation of pancreatic-like enzymes in serum, urine, and organ preparations. J. Biol. Chem. 1982, 257:8705-8710.
26. Gibbings D.J., Ciaudo C., Erhardt M., Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol. 2009, 11:1143-1149.
27. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
28. Iguchi H., Kosaka N., Ochiya T. Secretory microRNAs as a versatile communication tool. Commun. Integr. Biol. 2010, 3:478-481.
29. Camussi G., Deregibus M.C., Bruno S., Cantaluppi V., Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010, 78:838-848.
30. Muralidharan-Chari V., Clancy J.W., Sedgwick A., D'Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 2010, 123:1603-1611.
31. Pigati L., Yaddanapudi S.C., Iyengar R., Kim D.J., Hearn S.A., Danforth D., Hastings M.L., Duelli D.M. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 2010, 5:e13515.
32. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 2010, 285:17442-17452.
33. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., Curry W.T., Carter B.S., Krichevsky A.M., Breakefield X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10:1470-1476.
34. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., Xiao T., Schafer J., Lee M.L., Schmittgen T.D., Nana-Sinkam S.P., Jarjoura D., Marsh C.B. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008, 3:e3694.
35. Michael A., Bajracharya S.D., Yuen P.S., Zhou H., Star R.A., Illei G.G., Alevizos I. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 2010, 16:34-38.
36. Dimov I., Jankovic Velickovic L., Stefanovic V. Urinary exosomes. ScientificWorldJournal 2009, 9:1107-1118.
37. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., Sun F., Lu J., Yin Y., Cai X. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 2010, 39:133-144.
38. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A., Hopmans E.S., Lindenberg J.L., de Gruijl T.D., Wurdinger T., Middeldorp J.M. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6328-6333.
39. Hanke M., Hoefig K., Merz H., Feller A.C., Kausch I., Jocham D., Warnecke J.M., Sczakiel G. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol. Oncol. 2010, 28:655-661.
40. Lodes M.J., Caraballo M., Suciu D., Munro S., Kumar A., Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 2009, 4:e6229.
41. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10513-10518.
42. Zhao H., Shen J., Medico L., Wang D., Ambrosone C.B., Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010, 5:e13735.
43. Roth C., Rack B., Muller V., Janni W., Pantel K., Schwarzenbach H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 2010, 12:R90.
44. Heneghan H.M., Miller N., Lowery A.J., Sweeney K.J., Newell J., Kerin M.J. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann. Surg. 2010, 251:499-505.
45. Taylor D.D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 2008, 110:13-21.
46. Rai A.J., Gelfand C.A., Haywood B.C., Warunek D.J., Yi J., Schuchard M.D., Mehigh R.J., Cockrill S.L., Scott G.B., Tammen H., Schulz-Knappe P., Speicher D.W., Vitzthum F., Haab B.B., Siest G., Chan D.W. HUPO Plasma proteome project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005, 5:3262-3277.
47. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 2010, 127:118-126.
48. Ng E.K., Tsang W.P., Ng S.S., Jin H.C., Yu J., Li J.J., Rocken C., Ebert M.P., Kwok T.T., Sung J.J. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br. J. Cancer 2009, 101:699-706.
49. Liu C.J., Kao S.Y., Tu H.F., Tsai M.M., Chang K.W., Lin S.C. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis. 2010, 16:360-364.
50. Park N.J., Zhou H., Elashoff D., Henson B.S., Kastratovic D.A., Abemayor E., Wong D.T. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 2009, 15:5473-5477.
51. Ng E.K., Chong W.W., Jin H., Lam E.K., Shin V.Y., Yu J., Poon T.C., Ng S.S., Sung J.J. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
52. Resnick K.E., Alder H., Hagan J.P., Richardson D.L., Croce C.M., Cohn D.E. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 2009, 112:55-59.
53. Corsten M.F., Dennert R., Jochems S., Kuznetsova T., Devaux Y., Hofstra L., Wagner D.R., Staessen J.A., Heymans S., Schroen B. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ. Cardiovasc. Genet. 2010, 3:499-506.
54. Tijsen A.J., Creemers E.E., Moerland P.D., de Windt L.J., van der Wal A.C., Kok W.E., Pinto Y.M. MiR423-5p as a circulating biomarker for heart failure. Circ. Res. 2010, 106:1035-1039.
55. Ai J., Zhang R., Li Y., Pu J., Lu Y., Jiao J., Li K., Yu B., Li Z., Wang R., Wang L., Li Q., Wang N., Shan H., Li Z., Yang B. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem. Biophys. Res. Commun. 2010, 391:73-77.
56. Cheng Y., Tan N., Yang J., Liu X., Cao X., He P., Dong X., Qin S., Zhang C. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin. Sci. (Lond.) 2010, 119:87-95.
57. Ferracin M., Veronese A., Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev. Mol. Diagn. 2010, 10:297-308.
58. Tie Y., Liu B., Fu H., Zheng X. Circulating miRNA and cancer diagnosis. Sci. China C Life Sci. 2009, 52:1117-1122.
59. Fabbri M. miRNAs as molecular biomarkers of cancer. Expert Rev. Mol. Diagn. 2010, 10:435-444.
60. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4402-4407.
61. Mazer M., Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J. Med. Toxicol. 2008, 4:2-6.
62. Adachi T., Nakanishi M., Otsuka Y., Nishimura K., Hirokawa G., Goto Y., Nonogi H., Iwai N. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin. Chem. 2010, 56:1183-1185.
63. Li J., Yao B., Huang H., Wang Z., Sun C., Fan Y., Chang Q., Li S., Wang X., Xi J. Real-time polymerase chain reaction microRNA detection based on enzymatic stem-loop probes ligation. Anal. Chem. 2009, 81:5446-5451.
64. Thomas M.F., Ansel K.M. Construction of small RNA cDNA libraries for deep sequencing. Methods Mol. Biol. 2010, 667:93-111.
65. Sato F., Tsuchiya S., Terasawa K., Tsujimoto G. Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PLoS ONE 2009, 4:e5540.
66. Chen Y., Gelfond J.A., McManus L.M., Shireman P.K. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 2009, 10:407.
67. Lee L.W., Zhang S., Etheridge A., Ma L., Martin D., Galas D., Wang K. Complexity of the microRNA repertoire revealed by next-generation sequencing. RNA 2010, 16:2170-2180.
68. Fernandez-Valverde S.L., Taft R.J., Mattick J.S. Dynamic isomiR regulation in Drosophila development. RNA 2010, 16:1881-1888.
69. Omenn G.S. Exploring the human plasma proteome. Proteomics 2005, 5:3223-3225.
70. Goldstein S.L. Urinary kidney injury biomarkers and urine creatinine normalization: a false premise or not?. Kidney Int. 2010, 78:433-435.
71. Wagner B.D., Accurso F.J., Laguna T.A. The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population. J. Cyst Fibros. 2010, 9:212-216.
72. Czech B., Zhou R., Erlich Y., Brennecke J., Binari R., Villalta C., Gordon A., Perrimon N., Hannon G.J. Hierarchical rules for argonaute loading in Drosophila. Mol. Cell 2009, 36:445-456.